BSF Enterprise Plc (BSFA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BSF Enterprise Plc (BSFA) has a cash flow conversion efficiency ratio of -0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-278.20K ≈ $-33.85 USD) by net assets (GBX2.72 Million ≈ $330.69 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BSF Enterprise Plc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how BSF Enterprise Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BSF Enterprise Plc (BSFA) financial obligations for a breakdown of total debt and financial obligations.
BSF Enterprise Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BSF Enterprise Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FAT Brands Inc
NASDAQ:FATBW
|
0.050x |
|
Gaming Technologies Inc. Common Stock
NASDAQ:GMGT
|
0.110x |
|
Physiomics Plc
LSE:PYC
|
-0.514x |
|
Futura Medical
LSE:FUM
|
1.130x |
|
Hsin Yung Chien Co Ltd
TW:2114
|
0.010x |
|
Marechale Capital Plc
LSE:MAC
|
-0.059x |
|
Technology Minerals PLC
LSE:TM1
|
-0.017x |
|
Botswana Diamonds plc
LSE:BOD
|
-0.001x |
Annual Cash Flow Conversion Efficiency for BSF Enterprise Plc (2019–2025)
The table below shows the annual cash flow conversion efficiency of BSF Enterprise Plc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see BSF Enterprise Plc (BSFA) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | GBX2.72 Million ≈ $330.69 |
GBX-1.01 Million ≈ $-122.69 |
-0.371x | +25.58% |
| 2024-09-30 | GBX3.19 Million ≈ $388.18 |
GBX-1.59 Million ≈ $-193.52 |
-0.499x | -75.57% |
| 2023-09-30 | GBX4.86 Million ≈ $591.20 |
GBX-1.38 Million ≈ $-167.87 |
-0.284x | -52.48% |
| 2022-09-30 | GBX3.58 Million ≈ $435.94 |
GBX-667.24K ≈ $-81.18 |
-0.186x | +20.25% |
| 2021-09-30 | GBX364.82K ≈ $44.39 |
GBX-85.19K ≈ $-10.37 |
-0.234x | +7.77% |
| 2020-09-30 | GBX423.14K ≈ $51.48 |
GBX-107.14K ≈ $-13.04 |
-0.253x | -121.19% |
| 2019-09-30 | GBX516.99K ≈ $62.90 |
GBX-59.18K ≈ $-7.20 |
-0.114x | -- |
About BSF Enterprise Plc
BSF Enterprise Plc develops and commercializes cutting-edge tissue-engineered solutions. It offers lab-grown leather, cultivated meat, and corneal repair technologies. The company was incorporated in 2018 and is based in London, United Kingdom.